Blau Farmacêutica S.A.

BOVESPA:BLAU3 Stock Report

Market Cap: R$2.7b

Blau Farmacêutica Balance Sheet Health

Financial Health criteria checks 6/6

Blau Farmacêutica has a total shareholder equity of R$2.1B and total debt of R$509.8M, which brings its debt-to-equity ratio to 24.5%. Its total assets and total liabilities are R$3.2B and R$1.2B respectively. Blau Farmacêutica's EBIT is R$265.9M making its interest coverage ratio 18.6. It has cash and short-term investments of R$431.9M.

Key information

24.5%

Debt to equity ratio

R$509.83m

Debt

Interest coverage ratio18.6x
CashR$431.95m
EquityR$2.08b
Total liabilitiesR$1.16b
Total assetsR$3.24b

Recent financial health updates

Recent updates

Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 07
Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Nov 06
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings

Aug 29
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings

Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Jun 28
Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

Feb 01
Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

May 14
What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Feb 24
Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Oct 14
Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Aug 17
Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Financial Position Analysis

Short Term Liabilities: BLAU3's short term assets (R$1.6B) exceed its short term liabilities (R$455.8M).

Long Term Liabilities: BLAU3's short term assets (R$1.6B) exceed its long term liabilities (R$701.0M).


Debt to Equity History and Analysis

Debt Level: BLAU3's net debt to equity ratio (3.7%) is considered satisfactory.

Reducing Debt: BLAU3's debt to equity ratio has reduced from 91.5% to 24.5% over the past 5 years.

Debt Coverage: BLAU3's debt is well covered by operating cash flow (65.2%).

Interest Coverage: BLAU3's interest payments on its debt are well covered by EBIT (18.6x coverage).


Balance Sheet


Discover healthy companies